www.scientificamerican.com
1 month agoThe Supreme Court's mifepristone decision could make abortions harder to access and challenge the FDA's authority to regulate all drugs and devices
Potential impact of Supreme Court case on abortion access and FDA authority
Implications of limiting FDA's regulatory authority on healthcare products [ more ]